UCB SA UCB.BR
BE · Euronext Brussels · XBRU · stock · Healthcare · website
UCB SA statistics & valuation
Market cap€40.5B
P / E26.0×
P / S5.2×
P / B3.7×
P / FCF22.0×
Dividend yield0.65%
Net margin20.1%
Return on equity14.3%
FCF margin23.8%
Net cash€6.0M
Enterprise value USD$46.8B
Earnings yield EBIT/EV5%
Return on capital14.6%
Graham number -52.2%€101.48
Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value (€101.48); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 74.3% | 71.5% | 67.5% | 69.6% |
| Operating margin | 25.9% | 13.8% | 12.1% | 12.7% |
| Net margin | 20.1% | 17.3% | 6.5% | 7.6% |
| FCF margin | 23.8% | 15.0% | 8.5% | 13.6% |
| Return on assets | 8.6% | 6.1% | 2.2% | 2.6% |
| Return on equity | 14.3% | 10.6% | 3.8% | 4.6% |
| Debt / equity | 0.19× | 0.28× | 0.32× | 0.28× |
| Current ratio | 1.38 | 1.36 | 1.32 | 1.06 |
Computed from company filings · BE · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.